(Q34553539)

3 August 2017

Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress (English)

1 reference

3 August 2017

Jennifer Adelson Mitty

1

1 reference

3 August 2017

Valerie E Stone

2

1 reference

3 August 2017

Michael Sands

3

1 reference

3 August 2017

Grace Macalino

4

1 reference

3 August 2017

Timothy Flanigan

5

1 reference

3 August 2017

language of work or name

English

0 references

publication date

27 February 2002

1 reference

Clinical Infectious Diseases

3 August 2017

1 reference

3 August 2017

34

1 reference

3 August 2017

7

1 reference

3 August 2017

984-990

1 reference

Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice

3 August 2017

1 reference

Medication adherence strategies for drug abusers with HIV/AIDS.

21 January 2018

1 reference

Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel

21 January 2018

1 reference

Tuberculosis in New York City--turning the tide

21 January 2018

1 reference

Expanding directly observed therapy: tuberculosis to human immunodeficiency virus

21 January 2018

1 reference

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

21 January 2018

1 reference

Provider assessment of adherence to HIV antiretroviral therapy.

21 January 2018

1 reference

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

21 January 2018

1 reference

An open-label pilot study of the efficacy and tolerability of once-daily didanosine versus twice-daily didanosine.

21 January 2018

1 reference

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

21 January 2018

1 reference

Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults

21 January 2018

1 reference

Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients

21 January 2018

1 reference

Safety and pharmacokinetics of once-daily regimens of soft-gel capsule saquinavir plus minidose ritonavir in human immunodeficiency virus-negative adults

21 January 2018

1 reference

Directly observed therapy in HIV therapy: A realistic perspective?

21 January 2018

1 reference

Community-based approaches to HIV treatment in resource-poor settings

21 January 2018

1 reference

Modified directly observed therapy for treatment of human immunodeficiency virus

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/339447

1 reference

3 August 2017

1 reference